Prevention of blood clots during varicose vein treatment
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18).
- You are scheduled for an endovenous procedure for trunk varicose veins using local anesthesia.
- Your planned treatment method includes one of these: radiofrequency, laser, mechanochemical, foam sclerotherapy, or cyanoacrylate (glue).
- You do not need full-dose blood thinners for another reason (like atrial fibrillation).
- You have no personal or close-family history of blood clots in the legs/lungs (VTE) and you don’t have known clotting disorders (thrombophilia).
- You don’t have bleeding problems or unsafe recent events (like recent major surgery/trauma or recent stroke), and you can consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.